NCT04038320 is a clinical trial of Sofosbuvir/ledipasvir (SOF/LDV) in Hepatitis C Virus, sponsored by Right to Care.

Who is sponsoring NCT04038320?

NCT04038320 is sponsored by Right to Care.

What drugs are being tested in NCT04038320?

Interventions in NCT04038320: Sofosbuvir/ledipasvir (SOF/LDV).

What condition does NCT04038320 study?

NCT04038320 studies Hepatitis C Virus.

Is NCT04038320 still recruiting?

NCT04038320 is currently completed. Last updated 30 July 2019.

Last reviewed 2019-07-30 · How we verify

NCT04038320

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Simplified Antiviral Treatment Strategy for Hepatitis C in Ukraine

Completed Last updated 30 July 2019

What this trial tests

trial testing Sofosbuvir/ledipasvir (SOF/LDV) in Hepatitis C Virus in 868 participants. Completed in 30 June 2019.

Timeline

26 March 2018

Primary endpoint
30 March 2019

30 June 2019

Quick facts

Lead sponsor	Right to Care
Status	Completed
Study type	OBSERVATIONAL
Enrollment	868
Start date	26 March 2018
Primary completion	30 March 2019
Estimated completion	30 June 2019
Sites	2 locations across Ukraine

Drugs / interventions tested

Sofosbuvir/ledipasvir (SOF/LDV) — full drug profile →

Conditions studied

Hepatitis C Virus — all drugs for Hepatitis C Virus →

Sponsor

Right to Care — full company profile →

Who can join

18 and older, any sex, with Hepatitis C Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project will evaluate cost and treatment outcomes of a simplified Hepatitis C Virus (HCV) testing, treatment and care model integrated with HIV testing and treatment among key affected populations in Ukraine.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine.
Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, et al · · 2022 · cited 1× · PMID 36514496 · DOI 10.1002/jgh3.12839

Verify or expand the search:

Other Right to Care trials

Trials by the same sponsor.

NCT03579576 — Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04038320 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Right to Care
Last refreshed: 30 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing